Key result
Women and men Veterans experienced comparable rates of 1-year major adverse cardiovascular events after percutaneous coronary intervention (adjusted HR 0.94).
Why the study?
Do women and men experience different 1-year major adverse cardiac outcomes after percutaneous coronary intervention in the Veterans Health Administration?
Cohort (n=64,757)
Yes
Do women and men experience different 1-year major adverse cardiac outcomes after percutaneous coronary intervention in the Veterans Health Administration?
Women and men Veterans undergoing PCI have comparable 1-year rates of rehospitalization for MI, mortality, and MACE despite differences in baseline clinical risk factors.
Answers are grounded in this paper and cite their sources.
Sex differences in post-PCI outcomes among veterans warrant prospective confirmation; leaves open generalizability and practice implications.
BACKGROUND: Advancements in percutaneous coronary intervention (PCI) for treating obstructive coronary artery disease have reduced major adverse events, including mortality. Yet, evidence as to whether women and men experience similar outcomes is mixed. The objective was to examine sex differences in 1-year major adverse cardiac outcomes for the national population of patients undergoing PCI at Veterans Health Administration (VA) cardiac catheterization laboratories. METHODS: All Veterans undergoing PCI at VA hospitals between October 1, 2007 and September 30, 2013 (N = 64,757; Women = 1,040) were included. Cox proportional hazards models compared 1-year postprocedural outcomes [rehospitalization for myocardial infarction (MI), all-cause mortality, and major adverse cardiovascular events (MACE)] by sex. RESULTS: Women Veterans undergoing PCI were more likely to be younger, black, obese, and have chronic depression and less likely to have common cardiovascular risk factors and to have had prior cardiac events than Veteran men. One-year rates for women versus men were 2.1% and 2.5% for rehospitalization (p-value = 0.57); 3.5% and 4.9% for mortality (p-value = 0.14), and 5.4% and 6.9% for MACE (p-value = 0.18). There were no significant sex differences in any of the outcomes in Cox proportional hazards models. CONCLUSIONS: Despite differences in clinical risk factors at the time of PCI, women and men Veterans treated at VA cardiac catheterization laboratories experienced comparable 1-year rehospitalization for MI, mortality, and MACE post-PCI. These results demonstrated similar 1-year post-PCI outcomes for men and women in a national population of patients who have more comorbidities and mental health issues than the general population.
No takes yet. Share an insight, caveat, or question.
Farmer et al. (2017) conducted a cohort in Obstructive coronary artery disease (n=64,757). Female sex vs. Male sex was evaluated on 1-year major adverse cardiovascular events (MACE) (HR 0.94, 95% CI 0.70-1.26, p=0.6624). Women and men Veterans experienced comparable rates of 1-year major adverse cardiovascular events after percutaneous coronary intervention (adjusted HR 0.94).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: